Risperidone for non-cognitive symptoms of dementia
暂无分享,去创建一个
[1] B. Lawlor,et al. A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia , 1999, Neurology.
[2] D. Jeste,et al. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group. , 1999, The Journal of clinical psychiatry.
[3] J. Wancata,et al. Prevalence and course of psychiatric disorders among nursing home admissions , 1998, European psychiatry.
[4] J. Wancata,et al. Psychotropic drug intake in residents newly admitted to nursing homes , 1997, Psychopharmacology.
[5] W. Honer,et al. Extrapyramidal signs and clinical symptoms in first-episode schizophrenia: response to low-dose risperidone. , 1997, Journal of clinical psychopharmacology.
[6] G. Simpson,et al. Extrapyramidal symptoms in patients treated with risperidone. , 1997, Journal of clinical psychopharmacology.
[7] S. Finkel. New Focus on Behavioral and Psychological Signs and Symptoms of Dementia , 1997, International Psychogeriatrics.
[8] D. Devanand. Antipsychotic Treatment in Outpatients With Dementia , 1997, International Psychogeriatrics.
[9] R. Goldberg,et al. Risperidone for Dementia-Related Disturbed Behavior in Nursing Home Residents: A Clinical Experience , 1997, International Psychogeriatrics.
[10] L. Schneider,et al. Optimal Management of Behavioural Disorders Associated with Dementia , 1997, Drugs & aging.
[11] W. Honer,et al. THE USE OF RISPERIDONE IN SEVERELY DEMENTED PATIENTS WITH PERSISTENT VOCALIZATIONS , 1997, International journal of geriatric psychiatry.
[12] C. Naranjo,et al. Behavioural Disorders in Demented Elderly Patients , 1996 .
[13] J. Peuskens,et al. Risperidone in the treatment of negative symptoms of schizophrenia: a meta‐analysis , 1995, International clinical psychopharmacology.
[14] Jodi Death,et al. Risperidone in the Treatment of Agitated and Aggressive Patients with Dementia , 1995 .
[15] P. Tariot,et al. Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose-response study. , 1987, Archives of general psychiatry.
[16] E. Richelson. Preclinical pharmacology of neuroleptics: focus on new generation compounds. , 1996, The Journal of clinical psychiatry.
[17] R. Antonijoan,et al. Evaluation of psychotropic drug consumption related to psychological distress in the elderly: hospitalized vs. nonhospitalized. , 1990, Neuropsychobiology.
[18] H. Bickel,et al. Old People in Hospital: A Study of a Psychiatric High-Risk Group , 1987 .